J.W. Coons Advisors’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$838K Buy
1,542
+45
+3% +$23.5K 0.19% 114
2025
Q1
$741K Buy
1,497
+20
+1% +$11.1K 0.2% 111
2024
Q4
$771K Sell
1,477
-97
-6% -$50.5K 0.2% 108
2024
Q3
$773K Buy
1,574
+4
+0.3% +$1.86K 0.19% 111
2024
Q2
$698K Buy
1,570
+60
+4% +$23.9K 0.17% 114
2024
Q1
$603K Buy
1,510
+340
+29% +$128K 0.14% 133
2023
Q4
$395K Buy
1,170
+66
+6% +$19.7K 0.11% 161
2023
Q3
$323K Hold
1,104
0.09% 174
2023
Q2
$378K Buy
1,104
+30
+3% +$9.08K 0.1% 169
2023
Q1
$274K Hold
1,074
0.08% 200
2022
Q4
$285K Buy
1,074
+2
+0.2% +$488 0.09% 190
2022
Q3
$201K Hold
1,072
0.08% 207
2022
Q2
$213K Sell
1,072
-54
-5% -$12.7K 0.08% 231
2022
Q1
$358K Sell
1,126
-262
-19% -$76.5K 0.11% 181
2021
Q4
$498K Buy
1,388
+470
+51% +$162K 0.15% 148
2021
Q3
$305K Buy
918
+15
+2% +$5.04K 0.1% 174
2021
Q2
$279K Sell
903
-42
-4% -$11.8K 0.1% 180
2021
Q1
$232K Hold
945
0.08% 202
2020
Q4
$257K Hold
945
0.1% 177
2020
Q3
$223K Buy
+945
New +$212K 0.09% 180

Other funds holding ISRG

J.W. Coons Advisors's ISRG Position: Q2 2025 in Review

J.W. Coons Advisors increased its Intuitive Surgical (ISRG) stake by 3% in Q2 2025, buying an estimated $23.5K and bringing the position to 1,542 shares worth $838K. The position accounts for 0.19% of the portfolio, ranked #114.

J.W. Coons Advisors first reported a position in ISRG in Q3 2020 and has held it in 20 quarters since. 2,265 funds tracked by Wall St. Rank hold ISRG as of Q2 2025.

  • J.W. Coons Advisors held 1,542 shares of Intuitive Surgical worth $838K as of Q2 2025.
  • J.W. Coons Advisors bought 45 Intuitive Surgical shares in Q2 2025, an estimated $23.5K.
  • Intuitive Surgical made up 0.19% of J.W. Coons Advisors's portfolio in Q2 2025, its #114 holding.
  • J.W. Coons Advisors first reported a position in Intuitive Surgical in Q3 2020 and has held it in 20 quarters since.
  • 2,265 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2025.

Based on J.W. Coons Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.